Get the Stockscreener App
7.32
4.42%
0.31
Pre-market:
7.31
-0.01
-0.14%
Nu Skin Enterprises Inc stock is traded at $7.32, with a volume of 621.05K.
It is up +4.42% in the last 24 hours and up +10.91% over the past month.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
See More
Previous Close:
$7.01
Open:
$7
24h Volume:
621.05K
Relative Volume:
0.80
Market Cap:
$363.88M
Revenue:
$1.97B
Net Income/Loss:
$8.60M
P/E Ratio:
40.67
EPS:
0.18
Net Cash Flow:
$60.15M
1W Performance:
+6.55%
1M Performance:
+10.91%
6M Performance:
-27.81%
1Y Performance:
-57.88%
1-Day Range:
$6.94
$7.38
1-Week Range:
$6.77
$7.38
52-Week Range:
$5.95
$19.30
Nu Skin Enterprises Inc Stock (NUS) Company Profile
Name
Nu Skin Enterprises Inc
Sector
Industry
Phone
801-345-1000
Address
75 WEST CENTER ST, PROVO, UT
Compare NUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUS
Nu Skin Enterprises Inc
|
7.32 | 363.88M | 1.97B | 8.60M | 60.15M | 0.18 |
|
PG
Procter Gamble Co
|
161.72 | 379.90B | 83.91B | 14.32B | 15.85B | 5.80 |
|
UL
Unilever Plc Adr
|
56.91 | 140.75B | 64.93B | 7.15B | 0 | 2.832 |
|
CL
Colgate Palmolive Co
|
88.23 | 72.08B | 20.11B | 2.87B | 3.40B | 3.49 |
|
KMB
Kimberly Clark Corp
|
126.52 | 42.19B | 20.10B | 2.61B | 2.90B | 7.71 |
|
KVUE
Kenvue Inc
|
20.80 | 39.88B | 15.46B | 1.06B | 1.40B | 0.55 |
Nu Skin Enterprises Inc Stock (NUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-31-23 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-21 | Downgrade | DA Davidson | Buy → Neutral |
| Oct-02-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Jul-02-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-02-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-09-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-05-19 | Resumed | Citigroup | Neutral |
| Nov-06-19 | Downgrade | Citigroup | Buy → Neutral |
| Oct-30-19 | Upgrade | Stifel | Sell → Hold |
| Jul-17-19 | Downgrade | DA Davidson | Buy → Neutral |
| Jul-17-19 | Downgrade | Jefferies | Buy → Hold |
| Jun-19-19 | Reiterated | BofA/Merrill | Underperform |
| May-01-19 | Reiterated | BofA/Merrill | Underperform |
| May-01-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-12-19 | Reiterated | BofA/Merrill | Underperform |
| Mar-25-19 | Downgrade | Stifel | Hold → Sell |
| Dec-06-18 | Reiterated | BofA/Merrill | Underperform |
| Oct-10-18 | Initiated | DA Davidson | Buy |
| Aug-03-18 | Upgrade | Stifel | Sell → Hold |
| Jun-14-18 | Initiated | Jefferies | Buy |
| Feb-16-18 | Reiterated | Stifel | Sell |
| Jan-23-18 | Reiterated | Citigroup | Buy |
View All
Nu Skin Enterprises Inc Stock (NUS) Latest News
NUS Q4 Preliminary Revenues Reach Top End of Outlook, Stock Gains 9.8% - MSN
What Does Nu Skin's Mavely Sale Mean for Its Long-Term Strategy? - MSN
Nu Skin Enterprises rises 4.3%, sells Mavely platform for $250 million - MSN
Barclays PLC Raises Stake in Nu Skin Enterprises, Inc. (NYSE:NUS) - MarketBeat
Nu Skin hits Q4 revenue target, to present at ICR Conference - Investing.com Canada
Nu Skin (NUS) Surges on Strong Guidance and Strategic Updates - GuruFocus.com
Nu Skin rallies after favorable guidance update - MSN
Nu Skin hits Q4 revenue target, to present at ICR Conference By Investing.com - Investing.com South Africa
Nu Skin Enterprises (NYSE:NUS) Releases Q4 2024 Earnings Guidance - MarketBeat
Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance - Business Wire
Institutional owners may take dramatic actions as Nu Skin Enterprises, Inc.'s (NYSE:NUS) recent 17% drop adds to one-year losses - Simply Wall St
Nu Skin: New Cash From Mavely's Sale Could Accelerate Inorganic Growth (NYSE:NUS) - Seeking Alpha
Nu Skin Enterprises jumps on a deal to sell its Mavely marketing tech platform - MSN
Nu Skin Enterprises announces strategic transaction of Mavely for $250M - Utah Business
Nu Skin Enterprises (NUS) Stock Dips Amid Market Volatility - GuruFocus.com
Nu Skin Sells Its Mavely Amidst Industry Competition - GuruFocus.com
Later Acquires Mavely for $250 Million, Unlocking New Opportunities for Marketers and Creators to Maximize their Return on Social - Marketscreener.com
Nu Skin Sells Mavely Platform to Later for $250M - Yahoo Finance
Nu Skin unit sells Mavely platform to Later for $250 million - Investing.com Nigeria
Nu Skin’s Rhyz Sells Mavely in $250 Million Strategic Transaction - Direct Selling News
Nu Skin’s Rhyz completes sale of Mavely for $250M - MSN
Nu Skin (NUS) Soars on Sale of Mavely Platform - GuruFocus.com
Nu Skin (NUS) Up 17% at Pre-Market Trade After Raising $250M Fresh Funds - MSN
Nu Skin (NUS) Shares Skyrocket, What You Need To Know - Yahoo Finance
Nu Skin Enterprises jumps on a deal to sell its Mavely marketing technology platfo - Investing.com India
Nu Skin Enterprises’ Rhyz Sells Mavely Affiliate to Portfolio Company Later in $250 Million Cash Deal - Happi
Why Is Nu Skin Enterprises Stock Jumping Today? - Benzinga
Nu Skin Shares Rise Premarket on Sale of Mavely Platform - MarketWatch
Nu Skin Enterprises rallies, sells Mavely platform for $250 million (NYSE:NUS) - Seeking Alpha
Nu Skin Enterprises Inc Stock (NUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.04%
6.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):